NCT03403634 2022-03-02Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the LiverRoswell Park Cancer InstitutePhase 2 Completed19 enrolled 15 charts